GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA
Argitalpenak (221) Ikertzaileren baten partaidetza izan duten argitalpenak
filter_list
2025
-
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker: CHRONIC LYMPHOCYTIC LEUKEMIA
Leukemia
-
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
Blood, Vol. 145, Núm. 2, pp. 234-243
-
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients
British Journal of Haematology
-
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL
HemaSphere, Vol. 9, Núm. 1
-
Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model
Biomolecules, Vol. 15, Núm. 5
-
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL
Leukemia
-
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop
Clinical Pharmacology and Therapeutics
-
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
Haematologica, Vol. 110, Núm. 5, pp. 1126-1140
-
Regional patterns of early-onset colorectal cancer from the GEOCODE (Global Early-Onset COlorectal Cancer DatabasE)-European consortium: Retrospective cohort study
BJS Open, Vol. 9, Núm. 2
-
SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia
Scientific Reports, Vol. 15, Núm. 1
-
Sex Differences in Gut Microbiota and Their Relation to Arterial Stiffness (MIVAS Study)
Nutrients , Vol. 17, Núm. 1
-
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial
The Lancet Haematology, Vol. 12, Núm. 7, pp. e529-e541
2024
-
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation
Cancer Genetics, Vol. 284-285, pp. 5-11
-
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers
British Journal of Surgery, Vol. 111, Núm. 3
-
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis
American Journal of Hematology
-
Citogenética y biología molecular en hematología
Pregrado de Hematología (Asociación Española de Hematologia y Hemoterapia), pp. 149-186
-
Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology
PLoS Computational Biology, Vol. 20, Núm. 2
-
Detection of regions of homozygosity in an unusual case of frontonasal dysplasia
Molecular Cytogenetics , Vol. 17, Núm. 1
-
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552
-
Gut microbiota and its relationship with early vascular ageing in a Spanish population (MIVAS study)
European Journal of Clinical Investigation, Vol. 54, Núm. 9